Back
Avenue Therapeutics, Inc. 10K Form
Sell
38
ATXI
Avenue Therapeutics, Inc.
Last Price:
$0.35
Seasonality Move:
-18.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATXI News And Ratings
See the #1 stock for the next 7 days that we like better than ATXI
ATXI Financial Statistics
Sales & Book Value
| Annual Sales: | $1.4M |
|---|---|
| Cash Flow: | $383K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.12 |
| Price / Book: | 0.61 |
Profitability
| EPS (TTM): | -1.46490 |
|---|---|
| Net Income (TTM): | $-3.8M |
| Gross Margin: | $0 |
| Return on Equity: | -172.21% |
| Return on Assets: | -112.65% |
Avenue Therapeutics, Inc. Earnings Forecast
Key Avenue Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 5 years for ATXI is 0.00%.
-
The Selling, General & Administrative Expenses for ATXI have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 73.86% of Revenue.
-
The Net Earning history of ATXI is -209.90% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 7 years.
Avenue Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ATXI |
| CUSIP: | 05360L |
| Website: | avenuetx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 2.62 |
| Quick Ratio: | 2.61 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATXI Technical Analysis vs Fundamental Analysis
Sell
38
Avenue Therapeutics, Inc. (ATXI)
is a Sell
Is Avenue Therapeutics, Inc. a Buy or a Sell?
-
Avenue Therapeutics, Inc. stock is rated a SellThe current Avenue Therapeutics, Inc. [ATXI] share price is $0.35. The Score for ATXI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.